Cargando…

Expression and molecular profiles of the AlkB family in ovarian serous carcinoma

AlkB family of Fe (II) and α-ketoglutarate-dependent dioxygenases plays essential roles in development of ovarian serous carcinoma (OV). However, the molecular profiles of AlkB family in OV have not been clarified. The results indicated that the expression of ALKBH1/3/5/8 and FTO was lower in OV pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Yuan, Wu, Geting, Peng, Bi, Li, Juanni, Zeng, Shuangshuang, Yan, Yuanliang, Xu, Zhijie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064172/
https://www.ncbi.nlm.nih.gov/pubmed/33744868
http://dx.doi.org/10.18632/aging.202716
_version_ 1783682078124015616
author Cai, Yuan
Wu, Geting
Peng, Bi
Li, Juanni
Zeng, Shuangshuang
Yan, Yuanliang
Xu, Zhijie
author_facet Cai, Yuan
Wu, Geting
Peng, Bi
Li, Juanni
Zeng, Shuangshuang
Yan, Yuanliang
Xu, Zhijie
author_sort Cai, Yuan
collection PubMed
description AlkB family of Fe (II) and α-ketoglutarate-dependent dioxygenases plays essential roles in development of ovarian serous carcinoma (OV). However, the molecular profiles of AlkB family in OV have not been clarified. The results indicated that the expression of ALKBH1/3/5/8 and FTO was lower in OV patients while ALKBH2/4/6/7 expression was higher. There was a strong correlation between ALKBH5/7 and pathological stage of OV patients. Kaplan-Meier plotter revealed that OV patients with high ALKBH4 level showed longer overall survival (OS). However, patients with high levels of ALKBH5/6 and FTO showed shorter OS and progression-free survival (PFS). Genetic alterations using cBioPortal revealed that the alteration rates of FTO were the highest. We also found that the functions of AlkB family were linked to several cancer-associated signaling pathways, including chemokine receptor signaling. TIMER database indicated that the AlkB family had a strong relationship with the infiltration of six types of immune cells (macrophages, neutrophils, CD8+ T-cells, B-cells, CD4+ T-cells and dendritic cells). Next, DiseaseMeth databases revealed that the global methylation levels of ALKBH1/2/3/4/5/6/7/8 and FTO were all lower in OV patients. Thus, our findings will enhance the understanding of AlkB family in OV pathology, and provide novel insights into AlkB-targeted therapy for OV patients.
format Online
Article
Text
id pubmed-8064172
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Impact Journals
record_format MEDLINE/PubMed
spelling pubmed-80641722021-04-26 Expression and molecular profiles of the AlkB family in ovarian serous carcinoma Cai, Yuan Wu, Geting Peng, Bi Li, Juanni Zeng, Shuangshuang Yan, Yuanliang Xu, Zhijie Aging (Albany NY) Research Paper AlkB family of Fe (II) and α-ketoglutarate-dependent dioxygenases plays essential roles in development of ovarian serous carcinoma (OV). However, the molecular profiles of AlkB family in OV have not been clarified. The results indicated that the expression of ALKBH1/3/5/8 and FTO was lower in OV patients while ALKBH2/4/6/7 expression was higher. There was a strong correlation between ALKBH5/7 and pathological stage of OV patients. Kaplan-Meier plotter revealed that OV patients with high ALKBH4 level showed longer overall survival (OS). However, patients with high levels of ALKBH5/6 and FTO showed shorter OS and progression-free survival (PFS). Genetic alterations using cBioPortal revealed that the alteration rates of FTO were the highest. We also found that the functions of AlkB family were linked to several cancer-associated signaling pathways, including chemokine receptor signaling. TIMER database indicated that the AlkB family had a strong relationship with the infiltration of six types of immune cells (macrophages, neutrophils, CD8+ T-cells, B-cells, CD4+ T-cells and dendritic cells). Next, DiseaseMeth databases revealed that the global methylation levels of ALKBH1/2/3/4/5/6/7/8 and FTO were all lower in OV patients. Thus, our findings will enhance the understanding of AlkB family in OV pathology, and provide novel insights into AlkB-targeted therapy for OV patients. Impact Journals 2021-03-19 /pmc/articles/PMC8064172/ /pubmed/33744868 http://dx.doi.org/10.18632/aging.202716 Text en Copyright: © 2021 Cai et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Paper
Cai, Yuan
Wu, Geting
Peng, Bi
Li, Juanni
Zeng, Shuangshuang
Yan, Yuanliang
Xu, Zhijie
Expression and molecular profiles of the AlkB family in ovarian serous carcinoma
title Expression and molecular profiles of the AlkB family in ovarian serous carcinoma
title_full Expression and molecular profiles of the AlkB family in ovarian serous carcinoma
title_fullStr Expression and molecular profiles of the AlkB family in ovarian serous carcinoma
title_full_unstemmed Expression and molecular profiles of the AlkB family in ovarian serous carcinoma
title_short Expression and molecular profiles of the AlkB family in ovarian serous carcinoma
title_sort expression and molecular profiles of the alkb family in ovarian serous carcinoma
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064172/
https://www.ncbi.nlm.nih.gov/pubmed/33744868
http://dx.doi.org/10.18632/aging.202716
work_keys_str_mv AT caiyuan expressionandmolecularprofilesofthealkbfamilyinovarianserouscarcinoma
AT wugeting expressionandmolecularprofilesofthealkbfamilyinovarianserouscarcinoma
AT pengbi expressionandmolecularprofilesofthealkbfamilyinovarianserouscarcinoma
AT lijuanni expressionandmolecularprofilesofthealkbfamilyinovarianserouscarcinoma
AT zengshuangshuang expressionandmolecularprofilesofthealkbfamilyinovarianserouscarcinoma
AT yanyuanliang expressionandmolecularprofilesofthealkbfamilyinovarianserouscarcinoma
AT xuzhijie expressionandmolecularprofilesofthealkbfamilyinovarianserouscarcinoma